Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Cyclacel Pharmaceuticals, Inc. See All Filings	D	2025-03-25 14:19:16 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers N/A CIK Number 0001130166 Filed Document 0001829126-25-002044 Exclusions or Exemptions 506b Accepted Date 2025-03-25 14:19:16 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Cyclacel Pharmaceuticals, Inc. See All Filings	D	2025-02-14 16:56:59 UTC
Amount To Be Raised $25,000,000 Associated Brokers / Dealers N/A CIK Number 0001130166 Filed Document 0001829126-25-001007 Exclusions or Exemptions 506b Accepted Date 2025-02-14 16:56:59 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Cyclacel Pharmaceuticals, Inc. See All Filings	D	2025-02-14 16:56:28 UTC
Amount To Be Raised $0 Associated Brokers / Dealers N/A CIK Number 0001130166 Filed Document 0001829126-25-001006 Exclusions or Exemptions 506b Accepted Date 2025-02-14 16:56:28 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Cyclacel Pharmaceuticals, Inc. See All Filings	D	2024-11-26 06:38:15 UTC
Amount To Be Raised $2,062,112 Associated Brokers / Dealers H.C. Wainwright & Co. CIK Number 0001130166 Filed Document 0001104659-24-122795 Exclusions or Exemptions 506b Accepted Date 2024-11-26 06:38:15 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Cyclacel Pharmaceuticals, Inc. See All Filings	D	2024-05-17 09:56:58 UTC
Amount To Be Raised $8,000,000 Associated Brokers / Dealers H.C. Wainwright & Co. CIK Number 0001130166 Filed Document 0001104659-24-062806 Exclusions or Exemptions 506b Accepted Date 2024-05-17 09:56:58 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Cyclacel Pharmaceuticals, Inc. See All Filings	D	2021-01-04 10:54:42 UTC
Amount To Be Raised $7,000,000 Associated Brokers / Dealers N/A CIK Number 0001130166 Filed Document 0001780314-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-01-04 10:54:42 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity